Bayer et al. show that CD8+ T cells contribute to the adverse cardiac effect of doxorubicin administration, promoting fibroblast activation and inflammation through a mechanism dependent on IFNγ and the degranulation of granzyme B.
- Abraham L. Bayer
- Maria A. Zambrano
- Pilar Alcaide